Plain-English translation of NCT07906821 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing microwave ablation (MWA) as a newer, less invasive alternative to surgery for benign thyroid nodules that cause problems like difficulty swallowing, neck discomfort, or cosmetic concerns. Microwave ablation uses targeted heat, guided by ultrasound imaging, to shrink the nodule while protecting nearby sensitive structures in your neck. This treatment is performed under local anesthesia—meaning you stay awake but numb—rather than requiring general anesthesia and hospitalization like traditional surgery.
Many people have benign thyroid nodules that cause uncomfortable symptoms, but traditional surgical removal requires general anesthesia and carries risks of complications. This medication offers patients a minimally invasive option performed under local anesthesia that may achieve similar results with faster recovery and fewer side effects.
You likely qualify if…
You likely don't qualify if…
You would receive one microwave ablation procedure performed under local anesthesia at a medical center, guided by ultrasound imaging. After the procedure, you would return for follow-up clinic visits at 2 weeks, 3 months, 6 months, 1 year, 2 years, and 3 years to allow doctors to monitor how well the nodule has shrunk and ensure you are healing well. Each visit will include ultrasound imaging and other routine tests to track your progress.
AI-generated summary from trial data · Oct 31, 2026 · Not medical advice
Hong Kong